Abstract
In nature, thiolate‐based systems are the primary targets of divalent mercury (HgII) toxicity. The formation of Hg(Cys) x cores in catalytic and structural protein centers mediates mercury's toxic effects and ultimately leads to cellular damage. Multiple studies have revealed distinct HgII‐thiolate coordination preferences, among which linear HgII complexes are the most commonly observed in solution at physiological pH. Trigonal or tetrahedral geometries are formed at basic pH or in tight intraprotein Cys‐rich metal sites. So far, no interprotein tetrahedral HgII complex formed at neutral pH has been reported. Rad50 protein is a part of the multiprotein MRN complex, a major player in DNA damage‐repair processes. Its central region consists of a conserved CXXC motif that enables dimerization of two Rad50 molecules by coordinating ZnII. Dimerized motifs form a unique interprotein zinc hook domain (Hk) that is critical for the biological activity of the MRN. Using a series of length‐differentiated peptide models of the Pyrococcus furiosus zinc hook domain, we investigated its interaction with HgII. Using UV‐Vis, CD, PAC, and 199Hg NMR spectroscopies as well as anisotropy decay, we discovered that all Rad50 fragments preferentially form homodimeric Hg(Hk)2 species with a distorted tetrahedral HgS4 coordination environment at physiological pH; this is the first example of an interprotein mercury site displaying tetrahedral geometry in solution. At higher HgII content, monomeric HgHk complexes with linear geometry are formed. The Hg(Cys)4 core of Rad50 is extremely stable and does not compete with cyanides, NAC, or DTT. Applying ITC, we found that the stability constant of the Rad50 Hg(Hk)2 complex is approximately three orders of magnitude higher than those of the strongest HgII complexes known to date.
Keywords: affinity, Cys-rich protein, mercury toxicity, metal-sulfur cluster, stability constant
HgII toxicity: HgII targets the intermolecular ZnII‐binding site of DNA binding protein Rad50 to form the strongest metal complex in the living world and jeopardize the DNA repair mechanism.
Introduction
Divalent mercury (HgII) does not have strict preferences with respect to coordination number, although the most typical are 2, 3, or 4 depending on the type and spatial orientation of the ligands. [1] During complexation in an aqueous environment HgII tends to achieve linear geometry as it allows for formation of the shortest (strongest) bond,[ 2 , 3 , 4 ] yielding the highest energy stabilization. [5] Digonal coordination tends to keep the optimal angle between the bonds close to 180°. The increase in coordination number with ligands utilizing the same binding atom coincides with an increase of the bond length. In practice, three‐ and four‐coordinate HgII species are always distorted, regardless of the symmetry enforcement of the binding moiety. Furthermore, the discrepancy of the bond lengths is compensated, as the increase of one Hg−S bond length is counterbalanced by shortening of another one. [6] The most extreme example of the distortion is the T‐shaped geometry of a three‐coordinate species with two short Hg−S bonds and one weaker and longer oriented perpendicularly. [7] The bond lengths may vary significantly from the common values found for homoleptic mononuclear species when the coordinating atom bridges HgII in a dimer or repetitive dimeric center of the polymer.
In nature, thiolate‐based systems are the most common targets for HgII. [8] No biological functions of mercury have been found so far, and exposure to this metal leads to mercury poisoning. [9] Therefore, a binding event is usually related to toxic actions. On the other hand, thiolates are also engaged in metal sequestration and bioremediation mechanisms, transmembrane transport in bacteria (Mer protein superfamily) [10] and intracellular metal scavenging systems (e. g., metallothioneins)[ 11 , 12 ] in eukaryotic cells. At neutral pH conditions the low molecular weight compounds with one (N‐acetylcysteine) [13] or two (dithiothreitol) thiol groups form digonal HgII complexes as metal enforces its preferred binding mode. This phenomenon occurs even at higher ligand‐to‐metal ratios, where the HgS2 coordination environment, though in a mixture with HgS3, is still the predominant species in the solution. [14] Nevertheless, when the thiol ligands are structurally associated within a single polypeptide chain, where they are in a predefined spatial orientation and may sequester metal ions even in their protonated state, [2] the HgII binding mode is determined by the ligand. Mercury‐substituted rubredoxin, which sequesters the metal ion within a homoleptic tetrahedral thiolate HgS4 environment, [15] or metallothioneins forming metallic clusters engaging HgS2–4 binding modes are good examples of this phenomenon.[ 16 , 17 , 18 ] It is worth noting that these are the only examples of intramolecular Hg(Cys)4 protein centers existing in the neutral pH range. Although the soft thiolates are the major ligand donor atoms for HgII coordination, the toxic action of the metal may also affect mixed‐ligand[ 19 , 20 ] or histidine‐based enzymatic sites. [21]
Intermolecular HgII binding to macromolecules is usually related to the toxic activity of the metal and mechanistically relies on the formation of aggregates. Also here, in most cases the metal is majorly bound to thiolate groups,[ 22 , 23 , 24 ] though the metal promoted aggregation may as well be fulfilled through binding to other medium/soft donors such as imidazole nitrogen. [25] Formation of digonal HgII species is observed regardless of the accessibility of potential binding sites. Species of higher coordination number are formed at non‐physiological pH conditions (pH>9.0) that enforce proton dissociation from the adjacent residues and their subsequent binding to the metal center. [26] The relationship between HgII binding preferences of the protein and pH conditions is particularly manifested in solution, where the HgII sequestration pattern at the protein interface may differ from the solid state structure. Solid state studies of mercurated HAH1, a human copper chaperone, performed for species in the neutral pH range, suggest the presence of distorted trigonal or tetrahedral HgII sites formed within the protein dimer, [27] while solution studies reveal the formation of linear HgII complexes in similar pH conditions. [28]
Interprotein metal binding sites are formed by at least two protein molecules (or entities?) interacting in homo‐or heteromeric mode. The binding of a metal ion at protein interfaces is frequently related to distinctly different properties that either provide a critical scaffold for organization of a heteromeric multi‐subunit system or trigger a molecular switch.[ 29 , 30 ] Of note, within the assortment of natural interprotein metal binding sites, those incorporating ZnII are the most common. [24] Among those, the highly conserved zinc hook domain of the Rad50 protein has undergone the most comprehensive characterization of biological, structural and physicochemical properties (Figure 1a).[ 31 , 32 , 33 ] It is a component of the evolutionary conserved MR(N/X) (Mre11, Rad50, Xrs2/Nbs1) complex that plays a pivotal role in double‐stranded DNA damage signaling and repair (Figure S1 in the Supporting Information).[ 34 , 35 , 36 , 37 ]
Figure 1.

Structural representation of the hook domain from P. furiosus Rad50 and protein fragments used in this study. a) Crystal structure representation of the HgII complex with a 112 amino acid fragment (PDF ID: 1 L8D). [32] The yellow color in chain A highlights the Hk45 fragment. b) Central 14‐aa fragment corresponding in length to Hk14. c) Sequences of Hk14 and Hk45 model peptides. The amino acid sequence of Hk130 is given in the Supporting Information.
It consists of a long antiparallel coiled‐coil protruding from the globular ATPase/DNA‐binding domain that ends with a small β‐hairpin loop containing a Cys‐Xaa‐Xaa‐Cys (CXXC) motif involved in ZnII coordination (Figure 1b).
Two such motifs from separate Rad50 molecules form a unique Zn(Cys)4 interprotein core. This small interface together with surrounding electrostatic and hydrophobic interactions forms the zinc hook domain (Zn(Hk)2) that displays remarkably high complex stability due to the ZnII‐coupled folding process.[ 38 , 39 , 40 , 41 ] Solid state characterization of the central fragment of the Rad50 zinc hook domain from Pyrococcus furiosus took advantage of HgII as a probe for ZnII. [32] The four cysteine thiolates, two from each monomer coordinate the HgII ion in a distorted tetrahedral coordination sphere and increased the resolution of the crystal structure. However, as previous studies on similar systems with ZnII and CdII suggest, [28] this phenomenon does not necessarily occur in solution and dynamic equilibria occur.[ 33 , 39 ] To clarify this issue, in this study we performed state‐of‐the‐art studies on HgII sequestration using functional Rad50 hook domain models that have been successfully applied before to study sequence‐structure‐stability relations in this zinc domain.[ 33 , 39 ] We provide solid evidence that Rad50 is unique in its HgII binding properties, when compared to other similar systems, and preferably sequesters HgII within a pseudotetrahedral environment at pH conditions that would otherwise favor formation of linear species. Furthermore, against all odds, the extremely high thermodynamic stability of the Hg(Cys)4 complex exceeds the energy gain of the HgS2 coordination environment in digonal complex formation, typically the most stable form of HgII sequestration. This study also sheds a new light on the molecular basis of mercury genotoxicity, [42] indicating that not only intra‐ but also interprotein zinc sites are affected by HgII.
Results and Discussion
Our previous studies on the central fragments of the Rad50 protein from P. furiosus revealed unique sequence‐structure‐stability relations. They indicated that a 14 amino acid long central fragment (Hk14) is sufficient to form a highly structured minimal zinc hook domain and thus constitutes a good model for the β‐hairpin formed upon ZnII coordination. [38] The full zinc hook domain is composed of a 45 amino acid residues long fragment (Hk45, Figure 1c) and includes all hydrophobic and electrostatic interactions.[ 33 , 38 ] Finally, the fragment spanning 130 amino residues (Hk130) structurally overlaps in the initial X‐ray structures with ZnII and HgII. [32] Therefore, here we selected these three Rad50 fragments (Hk14, Hk45, and Hk130) to probe the HgII coordination environment regarding hook model length and thermodynamic stability. Table S1 presents all Rad50 fragments, indicating those that have been N‐ or C‐terminally modified (acetylation, FAM modification or amidation).
199Hg NMR spectroscopy
199Hg NMR measurements were used to probe the geometry of the HgII complexes of all zinc hook peptides. Even though all Hk45 samples were soluble in presence of HgII, no signal were detected at any HgII‐to‐peptide ratio. The reason might be the presence of intermediate exchange processes in solution that lie within the NMR timescale, leading to substantial line broadening and hence no detectable signal after spectra processing. Among the three examined Rad50 fragments, only the shortest, Hk14, gave sharp and easily detectable signals at various HgII‐to‐ligand ratios and under physiological and slightly alkaline pH conditions (Figure 2).
Figure 2.

199Hg NMR spectra of HgII complexes of 3 mM Hk14 with HgII prepared in 10 % D2O/90 % H2O: a) HgII/Hk14=1 : 2, pH 7.4; b) HgII/Hk14 1 : 2, pH 8.5; c) HgII/Hk14=1 : 1, pH 7.4. All spectra were recorded at 37 °C; the pH was manually adjusted to the desired values.
Spectra of the sample prepared with a 2 : 1 ratio of peptide to HgII at physiological pH yield a single HgII species with a 199Hg shift of −236 ppm (Figure 2a) that rationalizes the presence of a distorted tetrahedral HgS4 core. [20] Alkaline pH has a negligible effect on the chemical shift value indicating the same coordination environment of the HgII ion; however, the signal‐to‐noise ratio is slightly better (Figure 2b). A higher HgII‐to‐peptide ratio of 1 : 1 leads to the formation of a new major 199Hg signal with a chemical shift value at −959 ppm, which agrees with the chemical shift values reported for two‐coordinate HgII species.[ 43 , 44 ] In addition, for a minor, now rather broad signal characteristic for a HgS4 species is still observed at −239 ppm (Figure 2c).These results suggest a metal‐driven mechanism of peptide dimer formation at a metal‐to‐peptide ratio of 1 : 2, which is further stabilized by the rearrangement of the peptide scaffold, as discussed elsewhere.[ 33 , 38 , 39 ] The addition of subsequent aliquots of HgII leads to the dissociation of the complex, allowing the formation of linear HgS2 species that are preferably formed by HgII in the physiological pH range. [1] However, one may still note the presence of a Hg(Hk14)2 signal, which may indicate either a small excess of peptide over the metal ion or/and the rather uncommon preference of the hook domain model for tetrahedral HgII sequestration.
Probing HgS x sites with 199mHg PAC spectroscopy
All PAC spectra and fitted parameters are presented in Table S3 and Figures S2 and S3. In all cases, the PAC data are fitted satisfactorily with one or two nuclear quadrupole interactions (NQIs), a low frequency signal, NQI1, and a high frequency signal, NQI2. The low‐frequency signal, NQI1, with νQ =0.1–0.2 GHz (and asymmetry parameter, η, fixed to 1), is in good agreement with literature data for distorted tetrahedral HgS4 coordination.[ 15 , 45 ] The difference in the reported asymmetry parameter, η, is insignificant, because η is very difficult to determine accurately for low frequency 199mHg PAC signals, simply because only one (or less than one) oscillation of the perturbation function is measurable. The high frequency signal, NQI2, gives a frequency (and asymmetry parameter) very similar to linear HgS2 for the HK14 peptide under conditions of 1 : 1 Hg(II):HK14, νQ =1.48(2) GHz (η =0.22(2)), and a slightly higher frequency, νQ =1.60–1.67 GHz (η =0.0–0.2) in the remaining cases.[ 45 , 47 ] The higher frequency might be caused by slightly shorter Hg−S bond lengths in a HgS2 structure, or the signal could reflect a different species, possibly T‐shaped HgS3, but both interpretations are speculative, and no conclusions in this work rely on this signal. Several individual spectra were recorded for Hk14 at pH 8.5, and they displayed a systematic change from NQI1 (HgS4) towards NQI2 (νQ =1.60–1.67 GHz) as a function of time between preparation of the peptide stock solution to the initiation of the PAC experiment, thus indicating oxidation of the cysteine thiols. Moreover, the same high frequency signal is observed in all experiments with HK45 and HK130, implying that these samples may also be partially oxidised. Consequently, only the two spectra indicating no or very little oxidation were included in the main text (Figure 3).
Figure 3.

199mHg PAC data for HgII complexes of Hk14 peptide; a) HgII/Hk14=1 : 2, pH 8.5; b) HgII/Hk14=1 : 1, pH 7.4. Fourier‐transformed experimental data and fits are shown as thin and bold lines, respectively. For more details, see Table S2.
These data demonstrate that HgII binding to the Hk14 peptide at pH 8.5 and at a HgII‐to‐peptide ratio of 1 : 2, gives a very low frequency signal, in agreement with reference data for HgS4 coordination.[ 15 , 45 ] The low frequency component is also in accord with the distorted tetrahedral HgS4 geometry presented in the crystal structure of the Rad50 zinc hook. [48] Contrary to this, HgII bound to the Hk14 peptide at pH 7.4 and at HgII‐to‐peptide of 1 : 1 gives a high frequency signal, reflecting HgS2 coordination, [46] possibly with a minor component (∼10 % of the total amplitude) reflecting HgS4 coordination, see Table S3. Thus, these spectra are in excellent agreement with the 199Hg NMR spectra, as well as with the UV‐Vis absorption spectra recorded in this work, see Figures 2 and 6, respectively. The remaining data series are not completely void of information despite the partial oxidation, and indicate that the HgII coordination by the Hk45 and Hk130 peptides is also HgS4 under condition of HgII‐to‐peptide of 1 : 2 (Figure S3; although also a high‐frequency component is present). Moreover, the observed frequency of the low frequency signal is slightly higher than for the Hk14 peptide, implying that the tetrahedral HgS4 geometry is slightly more distorted in these longer model systems of the zinc hook (Table S3 and Figure S3).
Figure 6.

Electronic difference spectra of a) Hk14 and b) Hk45 Rad50 zinc hook fragments titrated with HgII. Spectra were recorded in 20 mM Tris⋅HCl, pH 7.4, 0.1 M NaClO4, 150 μM TCEP for 100 μM Hk14 and 50 μM Hk45, respectively; Hg(Hk)2 complex spectra (solid lines), HgHk complex spectra (dashed lines), oversaturated complex spectra (dotted lines). Inflection points at given wavelengths which correspond to the 1 : 2 and 1 : 1 ratios of c) HgII/Hk14 and d) HgII/Hk45, respectively.
MS‐monitored HgII binding to Hk peptides
Mass spectrometry‐based analysis of HgII‐Hk complexation shows a mixture of mono‐ and dimeric mercurated Hk14 and Hk45 complexes at neutral pH. Electrospray ionization mass spectrometry (ESI‐MS) spectra recorded for solutions containing HgII and Hk14 in a ratio of 1 : 2 reveal signals of monomeric apo‐Hk (m/z 1517.8 Da) next to HgHk ([HgHk14]+; m/z 1717.7 Da) and Hg(Hk)2 ([Hg(Hk14)2]2+; m/z 1618.2 Da) species (Figure 4a). Samples of HgII and Hk45 mixed in the same 1 : 2 ratio yield nearly the same set of species, apo‐Hk45 ([Hk45]4+; m/z 1291.9 Da), HgHk45 ([HgHk45]4+; m/z 1341.7 Da) as well as the 1 : 2 dimer Hg(Hk45)2 ([Hg(Hk45)2]7+; m/z 1504.9 Da; Figure 4b).
Figure 4.

HgII complexes of Hk peptides monitored by ESI‐MS (20 mM ammonium carbonate, pH 8.0). a) [Hk14]=1×10−4 M; HgII/Hk14 ratio 1 : 2; MeOH/H2O=50 : 50 and b) [Hk45]=1×10−4 M; HgII/Hk45 ratio 1 : 2; MeOH/H2O=50 : 50. Insets present isotopic profiles of detected species with experimental (lower layer) and simulated (upper layer) spectra, respectively.
In general, as the physical conditions of mass spectrometry measurements are rather harsh and the relatively high temperature make the thiolates more sensitive to oxidation, the equilibrium might be shifted towards the monomeric 1 : 1 complexes during the measurements. [49] In consequence, the intensities of the signals for the 1 : 2 species may not represent their abundance in the sample. For that reason, the results of mass spectrometry may be interpreted only qualitatively and not quantitatively when metal speciation is examined.
Spectropolarimetric HgII titration of Hk peptides
Far‐UV CD titrations, performed by the addition of HgII to metal‐free Hk14 and Hk45 peptides at pH 7.4, demonstrate extensive conformational changes upon HgII coordination (Figure 5). Spectra recorded up to a HgII‐to‐Hk14 ratio of 1 : 2 result in intensive bands at (−) 203 and (−) 226 nm and less intensive bands (ligand‐to‐metal charged transfer, LMCT) at (−) 267 and (+) 296 nm, respectively (Figure 5a). Significant changes of CD spectra upon metal complexation and appearance of the first two bands were also observed for the ZnII and CdII complexes with Hk14,[ 33 , 38 , 39 ] indicating formation short β‐hairpin in excess of Hk14 over HgII. Moreover, appearance of two less energetic LMCT bands at (+) 296 and (−) 269 nm indicates the presence of distorted tetrahedral species.[ 15 , 50 , 51 ] This together confirms that HgII is tetrahedrally coordinated by Hk14, analogously to ZnII and CdII. Spectra of Hk45 recorded for the same range of molar ratios demonstrate an almost identical scenario: appearance of two intensive bands at (−) 207 and (−) 220 nm and less energetic bands at (−) 273 and (+) 298 nm (Figure 5b). Changes in the relative intensity of the first two negative bands demonstrate formation of an α‐helical structure. The same behavior was observed previously for ZnII and CdII, where the formed helices were capable of coiled‐coil structure formation. The subtraction of the apo‐ spectrum from the CD spectrum of the 1 : 2 complex of Hk45 with HgII yields a spectrum typical for coiled‐coil helices as the band intensities at 221 and 209 nm of the difference spectrum give a ratio of 1.11 (Figure S4). [52]
Figure 5.

CD spectra of a) 100 μM Hk14 and b) 50 μM Hk45 Rad50 zinc hook fragments titrated with HgII. Spectra were recorded in 20 mM Tris⋅HCl buffer, pH 7.4, 0.1 M NaClO4, and 150 μM TCEP. Hg(Hk)2 complex spectra (solid lines), HgHk complex spectra (dashed lines), oversaturated complex spectra (dotted lines), apopeptide spectra (short dashed lines). c) and d) Relation between ellipticity at 228 nm and HgII/Hk molar ratios for Hk14 and Hk45, respectively.
The addition of more HgII to the Hk14 sample, that is, for ratios ranging from 1 : 2 to 1 : 1 causes significant decay of all bands, especially those at 203 to 226 nm (Figure 5a). Lower energetic bands evolve to one positive at 251 nm. Since the energy of transition is surprisingly high, it is difficult to discriminate digonal from trigonal T‐shaped HgII species. By analogy, the same scenario is observed for the Hk45 fragment of the zinc hook domain; however, the negative band at 220 nm originates from the combined effect of charge transfer evolution and peptide folding, which are difficult to dissect. Regardless of the zinc hook peptide fragment used, the relations between ellipticity at 226 nm presented in Figure 5c and d clearly indicate that at least three different HgII species are formed. At low HgII‐to‐peptide ratios a tetrahedral Hg(Hk)2 complex is formed, which turns to HgHk with digonal geometry at a ratio of 1 : 1. Additional HgII increases the CD signal decay due to a time‐dependent gradual increase of HgHk species formation or unspecific albeit still chiral binding of the excess HgII to the peptide fragment.
Spectrophotometric HgII titrations of the Hk peptides
Hk14 and Hk45 hook peptides were titrated with HgII analogously to the CD‐monitored titrations under analog conditions (Figure 6). The observed changes in absorbance during the titration of both peptides are consistent with the CD spectra. The linear absorbance increase at 241 and 276 nm in the case of Hk14 (Figure 6a) and 243 and 275 nm for Hk45 (Figure 6b) for HgII‐to‐Hk molar ratios up to 1 : 2 indicates the formation of Hg(Hk)2 species. The absorption maxima at these wavelengths are characteristic for spectroscopic signatures of distorted tetrahedral HgII species formed in solution under the used conditions.[ 15 , 28 ] Further addition of HgII results in a decay of the aforementioned electronic transitions and evolution of new bands at 224 and 212 nm for Hk14 and Hk45, respectively, occurs, indicating formation of a digonal complex with a stoichiometry of 1 : 1 (HgHk). The decay of LMCT bands and the transition from Hg(Hk)2 to HgHk proceeds differently for Hk14 (Figure 6c) and Hk45 (Figure 6d) and is less linear for the former than the latter. Substantially different behavior was also observed for ZnII and CdII in previous studies, probably due to the strong preference of these metal ions exclusively for tetrahedral geometry in the sulfur‐rich environment.[ 33 , 39 ] The negative value of absorbance in the difference spectra in the far‐UV range indicate that HgII binding enforces some structural rearrangements of the backbone in the structured part of Hk45. Unfortunately, discrimination between intra‐ and intermolecular coordination of HgII is not possible based on the observed spectroscopic pattern. Both complex types could have crucial consequences for the biological function of the zinc hook domain of the MRN complex. Purely intramolecular coordination would lead to permanent dissociation of the functional protein dimer, while formation of a coordinatively linked dimer, structurally different from the native ZnII‐bound protein assembly. Therefore, the evaluation of the association forms of the peptides, both as apo and mercurated species, is essential in understanding the mechanisms of HgII toxicity related to the structure and function of the zinc hook domain of the MRN protein.
SEC‐HPLC of HgII complexes of Hk peptides
A size‐exclusion‐HPLC analytical approach (SEC‐HPLC) was used to evaluate the dimerization/oligomerization state of the zinc hook complexes with HgII in more detail. For this, the apo‐peptides and variously mercurated samples were prepared in 20 mM Tris buffer, pH 7.4, with 150 mM NaF, and the same buffer was used for the SEC‐HPLC analysis. The results (Figure 7) prove that both Hk14 and Hk45 peptides form an intermolecular Hg(Hk)2 complex at a metal‐to‐Hk molar ratio of 0.9 : 2, which start to dissociate at a ratio of 0.9 : 1 and equilibrate at 1.5 : 1 in the form of monomeric HgHk complexes.
Figure 7.
SEC‐HPLC of metal‐free and mercurated Hk14 (a and b) and Hk45 (c and d) conducted in 20 mM Tris pH 7.4 with 150 mM NaF. Prepared injected samples were: metal‐free Hk (black line), 0.45 HgII/Hk molar ratio (red line), 0.9 HgII/Hk molar ratio (blue line) and 1.5 HgII/Hk molar ratio (green line). Chromatograms represent elution profiles as absorbance detected at wavelengths of 220 (top) and 280 nm (bottom) as a function of column volume (CV=5 mL). Dotted and dashed lines represent elution volumes corresponding to the Hg(Hk)2 biscomplex and HgHk monocomplex, respectively.
The retention time in SEC is inversely related to the hydrodynamic radius of the substance. The 220 nm absorbance originates from the protein backbone and (Figure 7a and c) is therefore proportional to the peptide chain length. In the chromatogram, two elution peaks are observed that can be assigned to the 1 : 1 and the 1 : 2 complex, respectively (shown as dashed and dotted lines). Moreover, the absorbance at 280 nm (Figure 7b and d), is mostly affected by the Hg−S LMCT bands of the tetrathiolate HgS4 coordination sphere that shows a maximum absorbance at 275 nm (Figure 6). Accordingly, the elution peaks with the lower retention time correspond to the larger Hg(Hk)2 complexes featuring the HgS4 coordination. In contrast, the peaks at the higher elution volume, indicative of particles of smaller hydrodynamic radius, present negligible 280 nm absorbance and thus can be clearly assigned to the HgHk complexes that show negligible Hg−S LMCT bands at this wavelength range (Figure 6). A clear dimerization followed by a dissociation process is observed for the Hk45 peptide where the apo‐form elutes at the monomer‐specific CV value (dashed line), then it dimerizes up to a HgII‐to‐Hk ratio of 0.9 : 2 and subsequently a rearrangement to the HgHk complex occurs under conditions of HgII excess. The insignificant uncoupling of observed complex composition from the adjusted HgII: Hk45 ratio is method‐specific and indicates the lack of system homogeneity in experimental conditions. In contrast, the apo‐Hk14 peptide elutes at the dimer‐specific CV value (dotted line) and stays in this range when mixed in a 0.9 : 2 ratio with HgII. Increasing HgII concentration again lead to the formation of the monomeric HgHk complex as for Hk45 (dashed line). These results suggest that in the applied experimental conditions apo‐Hk14 is not a monomer but rather a dimer formed either electrostatically or due to thiol oxidation (TCEP was not applied in this experiment due to interactions with HgII), as suggested by the visible peak at 280 nm wavelength at 0.76 CV.
Anisotropy decay analysis
In order to confirm the size‐exclusion results of Rad50 zinc hook assembly in complex with HgII we analyzed the anisotropy decay of N‐terminally FAM‐labeled Hk14 and Hk45 titrated with HgII. As the anisotropy decay is correlated with the molecule's dynamics and dimensions it is a very precise technique to measure the oligomeric state of proteins and fluorescently labeled peptides. [53] Fitting anisotropy decays provides the rotational correlation time (τ 1)–a parameter that delivers information on molecular dimensions in terms of their diffusion in a solvent. As τ describes how fast a fluorophore rotates, thus reducing its anisotropy, it is directly correlated with the hydrodynamic radius of emitting molecules. Rotational correlation time is calculated from Equation (1), as described in the experimental section.
| (1) |
where r(t) is the intensity, is the limiting anisotropy in the absence of rotational diffusion, τ j are the individual rotational correlation times and g j are the fractional amplitudes of each correlation time in the anisotropy decay ( ).
Figure 8 shows rotational correlation times of FAM‐Hk14 and FAM‐Hk45 as a function of the HgII‐to‐Hk molar ratio in the presence of 10× excess of DTT over the peptide. Addition of DTT protects the protein from oxidation, buffers the free HgII concentration in solution and did not influence the measured parameters unlike other HgII chelators tested. Both peptides present a linear increase of τ from 0 to 0.5 molar equivalents of HgII, which corresponds to the formation of Hg(Hk)2 complexes. Afterwards, τ decreases to apo‐like values, in line with previous results showing preferential formation of monomeric HgHk complexes at 1.0 molar equivalent of HgII. At the excess of HgII (>1 molar equivalent) τ values are scattered, which suggests the presence of complex equilibria; hence these points (gray crossed circles) were omitted from linear fitting and are not informative regarding the oligomeric state of the analyte. Interestingly, FAM‐Hk45 with a 100‐fold excess of DTT over peptide behaved substantially different and showed only a dimerization‐related τ increase and a negligible decrease at higher HgII molar equivalent values (Figure S5). This experiment suggests that while even a 100‐fold excess of DTT is not HgII‐competitive in the presence of the Hg(Hk45)2 complex, it is a stronger competitor than the HgHk45 monocomplex, which simply does not form in such conditions.
Figure 8.

Rotational correlation times (τ 1) of a) Hk14 and b) Hk45 represented as a function of HgII/Hk molar ratio. Error bars represent standard deviation of VV–VH decay difference fitting procedure; gray crossed points were not taken into account during τ 1 vs. HgII/Hk trait fitting. All measurements were carried out in a 50 mM HEPES buffer, pH 7.4, containing 150 mM NaCl and 3.5 μM DTT.
Competition of Hk peptides and low molecular weight thiols for HgII
As pointed out above, estimation of the apparent formation constant of Hg(Hk)2 complexes based on anisotropy decay experiments in the presence of DTT is impossible due to the lack of competition. Furthermore, the stability constant(s) of Hg(DTT) x complex(es) is not provided in the literature and cannot be used here for stability constant estimation. However, if one assumes that its constant is comparable to BAL, [54] a mercaptan, which like DTT contains two thiol groups, then it can be concluded that the HgHk45 monocomplex presents a slightly higher stability, while Hg(Hk45)2 is substantially stronger and approaches covalent‐like forces. We attempted to perform competitivity studies with a series of HgII chelators, including cyanides and DTT. However, regardless of the experimental conditions applied, Hg(Hk45)2 outcompeted the chelator, indicating the absence of metal‐buffering capacity in the desired affinity range. In fact, metal‐mediated folding of the hook domain peptide models applied in this work is completely unaffected by the HgII‐binding competitor (Figure S6), indicating that the protein, due to its high affinity, is able to sequester the desired amount of the metal irrespective of the presence of a competitive ligand.
ITC study: Considerations of HgII to Rad50 zinc hook affinity
Spectroscopic investigations on the competition between Hg(Hk)2 complexes and commonly used HgII chelators indicated that Hk14 and Hk45 Rad50 fragments form extremely stable complexes with HgII, with which known and classically used metal ion competitors are unable to compete and therefore obstruct the determination of stability constants. An alternative method that is frequently used to study metal‐peptide complex affinity is isothermal titration calorimetry (ITC). However, it must be underlined that ITC is not suitable for precise determination of tight affinities, and when applied, may yield underestimated formation constants.[ 55 , 56 ] As the system's affinity towards the natural metallic cofactor, ZnII, [39] exceeds the range of applicability of the method, direct determination of affinity constants from ITC experiments is not possible for metal ions known for their extreme thiophilicity, such as CdII or HgII.
In our approach, we assumed that the entropy changes (ΔS°) caused by ZnII, CdII and HgII coordination to Hk14 are comparable to each other due to the high structure similarity of the formed complexes and allow to calculate the free energy (ΔG) from Equation (2), when ΔH° of ZnII, CdII and HgII complexation is known.
| (2) |
The enthalpy change for ZnII and CdII binding to Hk14 in form of the MII(Hk14)2 complex as well as the stability constant K 12 [Eq. (3)] was determined previously using ITC.[ 33 , 39 ] K 12 is the cumulative formation constant of the ML2 species, which omits formation of the ML complex for simplicity or necessity in case of high cooperativity.
| (3) |
K 12 was then used to calculate ΔG of ZnII and CdII complexation [Eq. 4]
| (4) |
and subsequently the entropic factors, TΔS°, were obtained [Eq. (2), Table 1]. ▵H ITC for the Hk14 complexation with HgII was determined using continuous ITC (cITC) as presented in Figure 9.[ 57 , 58 , 59 ]
Table 1.
Thermodynamic parameters of ZnII, CdII, and HgII complexation to Hk14. The apparent log K 12 for HgII complexation at pH 7.4 was calculated assuming a TΔS° value identical as for ZnII, CdII or their averaged value.
|
Parameter |
ZnII[33,39] |
CdII[33] |
HgII[a] |
|---|---|---|---|
|
Mean ΔH ITC [kcal mol−1] |
−18.1 |
−21.6 |
−52.7 |
|
TΔS° [kcal mol−1] |
8.08 |
7.27 |
n. d. |
|
logK 12 (Hk14) |
19.2 |
21.2 |
44.2,[b] 44.5,[c] 43.9[d] |
|
|
|
|
44.2 (av.) |
|
logK 12 (Hk45) |
20.7 |
22.6 |
45.7 |
|
logK 12 (Hk130) |
20.8 |
22.7 |
45.8 |
[a] This study. [b] Value calculated assuming ΔS Hg=(ΔS Zn+ΔS Cd )/2. [c] Value calculated assuming ΔS Hg=ΔS Zn. [d] Value calculated assuming ΔS Hg=ΔS Cd. n. d.: not determined.
Figure 9.

a) ITC analysis of 200 μM Hk14 continuously titrated with 1.3 mM HgII, represented as a baseline‐subtracted heat rate as a function of time. b) Heat converted to molar enthalpy (ΔHITC) as a function of the HgII/Hk14 molar ratio. Presented graphs show the average of two titrations with the standard deviation for each point marked in red. All experiments were performed in 50 mM HEPES buffer, pH 7.4, in a buffer containing 150 mM NaNO3.
The use of cITC was necessary as we found that the Hg(NO3)2 concentration in 50 mM HEPES, pH 7.4 (0.15 M NaNO3) diminished over time. To reduce the effect of possible loss of HgII and to minimize the possible peptide oxidation the experimental time had to be kept to the minimum. ΔH ITC = −52.7 kcal mol−1 was calculated by averaging the plateau corresponding to the formation of a 1 : 2 complex from two independent titrations. Together with the entropic factor, TΔS°, of the ZnII and CdII complexes, the free enthalpy [Eq. (2)] and subsequently the stability constant K 12 for the Hg(Hk14)2 complex was calculated [Eq. (4)].[ 33 , 39 ] Assuming equal TΔS° values for all three MII(Hk)2 complexes a log =44.2 was determined for the Hg(Hk)2 complex. Assuming that the entropic factor for the formation of the Hg(Hk)2 complex agrees only with the ZnII or the CdII complex, respectively, slightly different values were obtained (log =44.5 vs. log =43.9, Table 1). Although these values are calculated based on the equal entropy assumption, they are still experimental values. In addition, as the determination is not based on HgII competition, it is free from any error of HgII‐competitor stability constants, which could have been under‐ or overestimated in the past. The only constants applied were the K 12 values of Zn(Hk14)2 and Cd(Hk14)2, which were determined with thoroughly using several independent techniques.[ 33 , 39 ] The ITC‐based approach was applied here only for Hk14 due to the system's simplicity; however, one may still estimate logK 12 for Hg(Hk45)2 and Hg(Hk130)2 based on the known stability constant shift between Zn(Hk14)2 and Zn(Hk45)2 or between Cd(Hk14)2 and Cd(Hk45)2. This logK 12 shift is 1.55 for the ZnII and 1.48 for the CdII hook complexes.[ 33 , 39 ] Taking the average value of the shift equal to 1.5, estimated log K 12 for Hg(Hk45)2 is 45.7. The analogous log K 12 constant for Hg(Hk130)2 based on CdII complexation by Hk130 is estimated to be 45.8 (Table 1). [33]
In order to compare the apparent formation constants of the Hg(Hk)2 complexes with HgII complexes with a 1 : 1 metal‐to‐ligand molar ratio, it is convenient to use the competitivity index (CI), which simplifies various stoichiometries in particular conditions (for details, see Table 2 footnote).[ 58 , 61 ] To place the determined stability constants of HgII‐Rad50 zinc hook complexes in a wider spectrum, it is best to compare them with the values evaluated for complexes of ligands representing chemically diverse classes, including classical chelating agents and thiolate compounds (Table 2). For instance, CI values of HgII complexes of iminodiacetic acid (IDA), nitriloacetic acid (NTA), N‐(2‐hydroxyethyl)ethylenediaminetriacetic acid (HEDTA), or ethylenediaminetetraacetic acid (EDTA) increase due to a more pronounced chelate effect and span the range from ∼13 to ∼20. Even in the case of the common potent chelator EDTA, the CI values of Hk complexes are nearly 25 orders of magnitude higher, reaching covalent bond strength. Ligands with established stability constants such as cyanides, cysteine, and N‐acetylcysteine, which have been used in this study, have significantly lower CI values. For that reason they are not able to compete with Hk peptides for HgII. The strongest HgII ligand described to date, the MerR protein, remains approximately three orders of magnitude weaker compared to the Hk peptides (Table 2). What factors contribute to such high stability of HgII complexes with hook domain fragments? The most important factor is the enthalpy effect from as many as four highly energetic Hg−S bonds formed during metal complexation. Other Cys‐containing ligands form HgII sites with digonal or T‐shaped geometry and two or three Hg−S bonds, respectively, at neutral pH.[ 26 , 28 , 51 ] Moreover, HgII binding causes major structural rearrangements associated with formation of the zinc hook domain in the metal‐coupled folding process. This additionally elevates the stability of the HgII complex due to the formation of β‐hairpin and energetically favored electrostatic and hydrophobic interactions, which contribute to the free energy of the complexation process.[ 33 , 39 ] It is worth emphasizing that symmetrical hook domain formation is possible only in the case of tetrahedral coordination. On the other hand, substantial energy release associated with folding adjustments and general stability increase [39] makes HgII more prone to form a tetrahedral center, quite uncommon for HgII complexes with natural products at neutral pH and until now never detected for interprotein assemblies in their natural milieu.
Table 2.
Affinities of selected low‐molecular‐weight ligands, peptides, and proteins for HgII, forming highly stable complexes, collected across the literature. Apparent formation constant for pH 7.4 was calculated only for ML2 complex based on protonation and stability constants determined by specified method in cited reference. Competitivity index was used to simplify stoichiometry of all formed HgII complexes in order to compare various ligands presented in the table.
|
Ligand |
Method of determination |
Conditions |
HgII species stoichiometry[a] |
Apparent formation constant logK 1, pH 7.4 |
Apparent formation constant logK 12, pH 7.4 |
CI[b] |
Ref. |
|---|---|---|---|---|---|---|---|
|
l‐Cys |
potentiometry |
100 mM NaClO4, 25 °C |
ML, ML2 |
32.3 |
35.5 |
33.6 |
[88] |
|
[89] | |||||||
|
potentiometry, radiometry |
protonation constants: 100 mM NaClO4, radiometry: 1 M NaClO4 |
ML2 |
n. c. |
33.9 |
30.6 |
[90] |
|
|
potentiometry |
0.225 M NaCl, 0.025 M NaI, 25 °C |
ML, ML2 |
25.9 |
37.5 |
34.2 |
[91] |
|
|
N‐acetyl‐l‐Cys (NAC) |
potentiometry |
protonation constant: 0.16 M NaNO3, 25 °C, stability constants: 0.1 M NaClO4, 25 °C |
ML, ML2 |
33.9 |
41.5 |
38.2 |
[92] |
|
[89] | |||||||
|
Reduced glutathione (GSH) |
potentiometry |
0.09 M NaCl and 0.01 M NaI |
ML, ML2 |
23.7 |
37.4 |
34.1 |
[91] |
|
potentiometry |
0.1 M KCl or KNO3, competition with DTPA |
ML, ML2 |
17.4 |
30.6 |
20.7 |
[93] |
|
|
polarography |
1 M KNO3 |
ML2 |
n. c. |
41.6 |
38.3 |
[94] |
|
|
Mercaptoacetic acid |
potentiometry |
0.1 M NaClO4 or KNO3, 25 °C |
ML2 |
n. c. |
38.4 |
35.1 |
[95] |
|
d‐penicillamine (PSH) |
potentiometry |
0.5 M NaClO4 |
ML2, ML3 |
n. c. |
n. d. |
31.9 |
[96] |
|
potentiometry |
0.1 M NaClO4 |
ML, ML2 |
34.5 |
37.1 |
34.9 |
[54] |
|
|
potentiometry |
0.1 M KNO3 |
ML |
12.5 |
n. c. |
12.5 |
[97] |
|
|
potentiometry |
0.15 M KNO3 |
ML, ML2 |
13.7 |
16.2 |
13.9 |
[98] |
|
|
potentiometry |
0.225 M NaCl, 0.025 M NaI |
ML, ML2 |
26.9 |
37.8 |
34.5 |
[91] |
|
|
potentiometry |
0.09 M NaCl, 0.01 M NaI |
ML, ML2 |
13.7 |
24.9 |
21.6 |
[91] |
|
|
2,3‐Dimercaptopropanol‐1 (BAL) |
potentiometry |
0.1 M NaClO4 |
ML, ML2 |
11.66 |
42.6 |
40.9 |
[54] |
|
Cyanide (CN−) |
potentiometry |
0.1 M NaNO3, 20 °C |
ML, ML2, ML3, ML4 |
n. c. |
n. c. |
27.8 |
[88] |
|
Chloride (Cl−) |
potentiometry |
0.1 M NaCl |
ML, ML2, ML3, ML4 |
n. c. |
n. c. |
10.1 |
[91] |
|
Iodide (I−) |
potentiometry |
0.1 M NaCl |
ML, ML2, ML3, ML4 |
n. c. |
n. c. |
21.1 |
[91] |
|
IDA[c] |
potentiometry |
0.1 M NaClO4 |
ML, ML2 |
8.72 |
16.39 |
13.11 |
[99] |
|
NTA[c] |
potentiometry |
0.5 M NaClO4 |
ML |
14.6 |
n. c. |
14.6 |
[95] |
|
HEDTA[c] |
potentiometry |
0.5 M NaClO4 |
ML |
20.5 |
n. c. |
20.5 |
[95] |
|
EDTA[c] |
potentiometry |
0.5 M NaClO4 |
ML |
21.5 |
n. c. |
21.5 |
[95] |
|
MerR protein |
competition |
100 mM sodium phosphate, 0.5 M NaCl, pH 7.0, 25 °C, 5 mM L‐cysteine |
ML (M2L2) |
39.4 |
n. c. |
39.4 |
[100] |
|
Hk14 |
ITC |
50 mM HEPES, pH 7.4, 150 mM NaNO3 |
ML2 |
n. c. |
44.2 |
40.9 |
this study |
|
Hk45 |
ITC |
– |
ML2 |
n. c. |
45.7 |
42.4 |
this study |
|
Hk130 |
ITC |
– |
ML2 |
n. c. |
45.8 |
42.5 |
this study |
[a] Protonation of presented complexes was omitted for clarity. [b] CI is the logarithm of the apparent dissociation constant of the HgL complex (HgII complex of theoretical molecule Z), where [HgZ]=Σ ijk [Hg i H j L k ] at given overall component concentrations. The concentrations of Z in calculations were set at 1 mM and HgII at 0.25 mM [60] . [c] IDA: iminodiacetic acid, NTA: nitriloacetic acid, HEDTA: N‐(2‐hydroxyethyl)ethylenediaminetriacetic acid, EDTA: ethylenediaminetetraacetic acid. n. c.: not calculated.
Biological significance of HgII coordination to Rad50
Rad50 is one of the most evolutionary conserved proteins in nature, as its homologs have been found in a plethora of organisms belonging to all three domains of life, and even in some viruses. [62] To fulfill its functions, thereby allowing for functioning of the entire MRN complex, Rad50 needs to bind ZnII in an intermolecular manner. Mre11 in the MRN complex is responsible for processing the broken DNA ends, while Rad50 plays a more structural role, acting as a long scaffold that can guide the whole MRN complex. [63] This is only possible if Rad50 dimerizes via the zinc hook, where the zinc intermolecular binding site is formed by the engagement of four thiolates, two from each protein unit, and results in a tetrahedral metal binding site. The Rad50 protein of P. furiosus, one of the extremophilic species of Archaea, was the first one to be structurally characterized and for a long time has served as a structural reference for all Rad50 homologs.[ 32 , 47 , 64 ] It is worth noting that the first crystal structure of the Rad50 hook domain was published for a holoprotein that sequestered HgII (PDB ID: 1 L8D) [32] instead of naturally occurring ZnII. The former metal ion was used as a isostructural probe for the latter as it gave better crystal resolution. Although the unique tetrahedral environment of HgII was formed at the protein interface, it was not the essence of the study and thus was not discussed by the authors. In fact, solid state studies, which provide detailed information on spatial position and orientation of the molecule, may not actually represent the natural biologically relevant status of a molecule in a dynamic cellular environment. For this reason, solution studies were more than necessary to confirm the extraordinary, though so far ignored, findings of Hopfner et al. [32] To elucidate whether or not the crystal structure illustrates the physiological picture of the Rad50 protein interaction with HgII, multi‐technique state‐of‐the‐art studies were performed on well‐designed functional peptidyl models of the protein hook domain in the physiological pH range. Application of mass spectrometry, size‐exclusion chromatography, and life‐time fluorescence spectroscopy identified the presence of HgII‐associated peptide dimers, while 199Hg NMR, 199mHg‐PAC, circular dichroism, and electronic spectroscopy confirmed the tetrathiolate HgS4 environment around the metal ion at the ratio favoring the formation of biscomplex species (M/L≤1 : 2) and digonal HgS2 coordination at equimolar ratios. Notably, the thermodynamic stability of the Hg(Cys)4 core formed at the protein interface was higher than that of the digonal HgS2 complex, as it could effectively compete with DTT used to buffer the HgII concentration. Application of the state‐of‐the‐art methodology of ITC allowed to evaluate the incredibly high affinity constant of the HgS4 species that is six orders of magnitude higher than the one of the strongest previously evaluated HgII system. This highlights the unique character of the interaction and to our knowledge makes the Rad50 zinc hook domain the most effective protein‐based HgII‐binding motif in nature. Metal‐coupled folding occurring in the hook domain during complexation makes its ZnII, CdII and HgII complexes significantly more stable than corresponding metallothioneins.[ 33 , 39 ] Even if Rad50 displays outstanding ZnII‐binding affinities, this interaction may be effectively disturbed in the presence of HgII ions. As has been mentioned before, to fulfill its functions the MRN complex must dimerize via Rad50’s zinc hook. Recent reports have indicated that switching between the various topological forms that Rad50 may adopt is crucial for binding to DNA substrates, as well as DNA end processing and repair. It is suggested that signals that induce conformation switching can be generated at two faraway poles of Rad50: at the ATPase globular domain and zinc hook, depending on the species placed 200–500 Å away from the globular domain.[ 37 , 65 , 66 , 67 , 68 ] This provides clear evidence that the zinc hook is not only an extraordinarily strong ZnII binding site, but is also involved in delicate MRN complex orchestration. This hypothesis is supported by our previous results suggesting that even small mutations such as point amino acid substitutions could damage DNA repair,[ 39 , 65 ] let alone the substitution of ZnII by another metal, altering the complex stability. In consequence, this manifestation of mercury toxicity might effectively upset the function of the Rad50 protein and the cell's ability to detect and repair lethal double‐strand DNA breaks. In fact, the accumulation of mercury inside the cell nucleus and its association with non‐histone proteins of chromatin after mercury exposure in mice, rats, or in isolated cells, was detected years ago.[ 69 , 70 , 71 , 72 , 73 , 74 , 75 ] HgII ions were also found to inhibit the DNA binding activity of the Cys2His2 zinc finger protein transcription factor III A and Sp1 in vitro, although no information on the HgII coordination was provided.[ 76 , 77 , 78 ] Importantly, the affinity of HgII towards Rad50 hook models examined in this study was found, not surprisingly, to be significantly higher than the affinity towards ZnII. Taken together, the zinc hook domain could serve as an excellent target for HgII binding and the resulting genotoxic activity.
Conclusions
Our comprehensive solution study reveals that the Rad50 zinc hook domain of P. furiosus sequesters HgII at the protein interface, forming an extremely stable distorted tetrahedral Hg(Cys)4 core with a HgS4 coordination environment in the physiological pH range. To the best of our knowledge, it is the first example of an interprotein‐based system that preferentially forms pseudotetrahedral and not the digonal HgII species at neutral pH in solution. Due to the extremely high affinity of HgII towards the Cys thiolates of the hook, it can easily displace ZnII from its coordination site. This feature makes it potentially genotoxic, as when entering the cell nucleus, HgII may bind to the Rad50 hook apex and exert a tremendous effect on the functioning of the entire MR(N/X) complex, in which the zinc hook and DNA‐binding globular domain are structurally and functionally intertwined.
Experimental Section
Materials: N,N‐Diisopropylethylamine (DIEA), 9‐fluorenylmethoxycarbonyl (Fmoc)‐protected amino acids (Fmoc‐Ala‐OH×H2O, Fmoc‐Arg(Pbf)‐OH, Fmoc‐Asn(Trt)‐OH, Fmoc‐Asp(OtBu)‐OH, Fmoc‐Cys(Trt)‐OH, Fmoc‐Gln(Trt)‐OH, Fmoc‐Gln(Trt)‐OH, Fmoc‐Glu(OtBu)‐OH, Fmoc‐Gly‐OH, Fmoc‐His(Trt)‐OH, Fmoc‐Ile‐OH, Fmoc‐Leu‐OH, Fmoc‐Lys(Boc)‐OH, Fmoc‐Met‐OH, Fmoc‐Phe‐OH, Fmoc‐Pro‐OH, Fmoc‐Ser(tBu)‐OH, Fmoc‐Thr(tBu)‐OH, Fmoc‐Tyr(tBu)‐OH, Fmoc‐Val‐OH), piperidine, and O‐(benzotriazol‐1‐yl)‐N,N,N’,N’‐tetramethyluronium hexafluorophosphate (HBTU) were purchased from Iris Biotech GmbH. HEPES and dithiothreitol (DTT) were purchased from Carl Roth GmbH, CdSO4 ⋅ H2O from Fluka Honeywell while NaNO3, ZnSO4 ⋅7 H2O, Hg(NO3)2 ⋅H2O were from Sigma–Aldrich. Trifluoroacetic acid (TFA), ethane‐1,2‐dithiol (EDT), thioanisole, anisole, triisopropylsilane (TIPS), guanidine hydrochloride (GdnHCl), 4‐mercaptophenylacetic acid, tris(2‐carboxyethyl)phosphine hydrochloride (TCEP), ethylenediaminetetraacetic acid (EDTA), and HCl (trace metal grade) were from Merck. Diethyl ether, acetic anhydride, dichloromethane (DCM), HgCl2 and NaCl were purchased from Avantor Performance Materials Poland S.A. Chelex 100 resin was from Bio‐Rad, 5,5′‐dithiobis(2‐nitrobenzoic acid) (DTNB) was from TCI Europe N.V., TentaGel R RAM and TentaGel S‐NH2 resins were from Rapp Polymere GmbH, and dimethylformamide (DMF) and acetonitrile (MeCN) were from VWR. 199HgO was purchased from Cambridge Isotope Labs. All of the experiments were performed in chelexed buffers and solutions. All buffers were prepared with Milli‐Q water obtained with a deionizing water system (Merck KGaA).
Peptide synthesis: Zinc hook peptides (Hk14 and Hk45) were synthesized by solid‐phase peptide synthesis (SPPS) using an Fmoc‐strategy on a TentaGel RRAM Amide Rink (Rapp Polymere, Tübingen, Germany) resin (substitution 0.2 mmol g−1) and a Liberty 1 microwave‐assisted synthesizer (CEM) as described previously. [79] Peptides were N‐terminally acetylated with acetic anhydride or fluorescently modified with a 5(6)‐carboxyfluorescein (FAM) derivative. [40] Cleaved peptides were precipitated and washed with cold diethyl ether and purified on a C18 column (Phenomenex) with a gradient of acetonitrile and 0.1 % TFA using a Dionex Ultimate 3000 HPLC system. The identity of peptides was confirmed with an API 2000 Applied Biosystems ESI‐MS instrument. Concentration of thiols was determined using a sulfhydryl‐group reactant, DTNB (ϵ 412 =14 150 M−1 cm−1), prior to each experiment. [80]
Expression and purification of metal‐free Hk130: The production of PF Hk130 relied on a previously established protocol using the pTYB21 expression vector (IMPACT Protein Purification System, NEB) and Escherichia coli BL21‐CodonPlus (DE3)‐RIL strain. [81] Transformed cells were cultivated in 4 L of LB or TB medium, respectively, and grown at 37 °C until OD600 was 0.4–0.5, and then induced with 0.1 mM IPTG. Cultures were incubated overnight at 20 °C with vigorous shaking and subsequently collected by centrifugation at 4500 g for 20 min at 4 °C. The pellets were resuspended in ice‐cold buffer A (20 mM HEPES, pH 8.0, 500 mM NaCl, 1 mM PMSF, 1 mM TCEP) and lysed by sonication on ice for 30 min, followed by centrifugation at 20 000 g for 15 min. Clarified cell extracts were incubated overnight with chitin resin at 4 °C with mild shaking. After the incubation, the resin was washed with 20 bed volumes of buffer A with increased salt concentration (1 M NaCl) to reduce nonspecific binding of other E. coli proteins. To induce the cleavage reaction, 25 mL of buffer B (20 mm HEPES, pH 8.0, 500 mM NaCl, 100 mM DTT) was added to the resin, and the mixture was incubated for 36–48 h at room temperature with mild shaking. Eluted protein solutions were acidified to pH ∼2.5–3.0 with 7 % HCl and concentrated to a small volume using AmiconUltra‐4 Centrifugal Filter Units with NMWL of 3 kDa (Merck Millipore, USA). Hk130 protein was purified by reversed‐phase HPLC in a 0.1 % TFA/acetonitrile gradient (Dionex) followed by lyophilization. The identity of the metal‐free Hk130 protein was confirmed by ESI‐MS, using an API 2000 instrument (Applied Biosystems, USA); the average molecular weight (MW) calculated was 15 217.8/15 217.6 Da (calculated/experimental).
Spectroscopic studies: The binding properties of the hook peptide were examined using electronic absorption spectroscopy and circular dichroism (CD). The electronic spectra and CD spectra of HgII complexes of hook peptides were recorded on a Jasco V‐630 spectrophotometer and a Jasco J‐1500 CD spectropolarimeter, respectively, in a 1 mm quartz cuvette in a wavelength range of 200–320 nm to observe LMCT transitions.[ 82 , 83 , 84 ] The experiments were performed in chelexed 20 mM TRIS buffer, pH 7.4, with 0.1 M NaClO4 and 150 μM TCEP. 100 μM solution of Hk14 and 50 μM Hk45 fragments were titrated with small aliquots of 50 mM HgCl2 to achieve a 0 to 2 molar ratio over the peptide. The application of TCEP as a thiol protective agent was limited as the HgII precipitates TCEP at higher concentrations. Based on the obtained absorption and ellipticity maxima, the M/L molar ratio was plotted at different wavelength values.
Mass spectrometry: High‐resolution mass spectra were obtained on a Bruker Q‐FT MS spectrometer equipped with an Apollo II electrospray ionization source with an ion funnel. The mass spectrometer was operated in the positive ion mode with the following parameters: scan range m/z 100–4000, dry gas‐nitrogen, temperature 170 °C, ion energy 5 eV. Capillary voltage was optimized to 4500 V to obtain the highest S/N ratio. The small changes of voltage (±500 V) did not significantly affect the optimized spectra. The samples (metal/ligand in a 1 : 2 stoichiometry, ligand=1×10−4 M) were prepared in a 1 : 1 mixture of 40 mM carbonate buffer and methanol. Variation of the solvent composition down to 5 % of MeOH did not change the speciation. The sample was infused at a flow rate of 3 mL min−1. The instrument was calibrated externally with the Tunemix mixture (Bruker Daltonik) in quadratic regression mode. Data were processed using the Bruker Compass Data Analysis 4.0 program. The mass accuracy for the calibration was higher than 5 ppm, enabling together with the true isotopic pattern (SigmaFit) unambiguous confirmation of the elemental composition of the obtained complex.
199 Hg NMR: The three Rad50 fragments, Hk14, Hk45, and Hk130, were dissolved in 10 % D2O/90 % H2O to obtain 2–3 mM solutions. After Ellman's test assay an appropriate amount of 199Hg(NO3)2 was added to the peptide samples to reach the desired HgII‐to‐Hk peptide ratio and a small amount of concentrated NaOH was used to adjust the pH to 7.4. At this step Hk130 irreversibly precipitated from the solution, while the complexes with Hk14 and Hk45 showed no sign of precipitation. All spectra were collected using a Bruker Avance 500 MHz spectrometer, equipped with a 5 mm BB inverse probe with an actively shielded z‐gradient coil tuned to 89.53 MHz for 199Hg. A solution of HgCl2 in D2O was used as an external reference, setting its peak at a position at −1560 ppm relative to Hg(CH3)2 (δ=0 ppm). [85] The spectral width of 1675 ppm was sampled using 30 000—80 000 scans. The spectra were processed using the software TopSpin (version 4.05).
199m Hg perturbed angular correlation (PAC) spectroscopy: PAC experiments provide information on the local structure and nanosecond dynamics at the probe site. [86] The experiments were conducted at ISOLDE/CERN in 2018, and the production of the radioisotope 199mHg was carried out as described by Iranzo et al. [46] The protein was prepared by resuspending lyophilized peptides in TRIS buffer (100 mM, pH 7.5 and 8.5). The following stock solutions were prepared and used for the PAC experiments: PF Hk14 (3.3 mM, concentration determined by Ellman's test), [80] Hk45 (1.8 mM), Hk130 (1.5 mM), TRIS buffer (1 M, pH 8.5), and HgCl2 (2.0 mM). The final samples contained the appropriate buffer (100 mM), peptide (200 μM or 100 μM), HgCl2 (100 μM) and sucrose (55 % w/w). The sucrose was added to slow the tumbling of proteins due to Brownian motion. A digital PAC instrument (DigiPAC) was used for these experiments, with a time per channel of 0.04883 ns, and a time resolution of 0.7 ns. The data collection and analysis were done with Prelude and Winfit software (developed by Tilman Butz et al., personal communication). 600 data points were used in the fits, excluding the first 9 points due to systematic errors in these. Fourier transformation was carried out using the same 600 data points and a Kaiser‐Bessel parameter of 10. Each nuclear quadrupole interaction (NQI) was modeled using a different set of parameters (ν Q, η, δ, and A) in addition to a parameter representing the rotational correlation time common to both NQIs, τ c (the two NQIs may have different rotational correlation times, but the software does not allow for such analysis). ν Q is the quadrupole coupling constant, η represents the asymmetry of the electric field gradient at the probe site (attaining a value of 0 in axially symmetric systems, and values up to 1 in a highly asymmetrical system), δ is the relative frequency spread, and A is the amplitude of the signal.
Size‐exclusion chromatography (SEC): Gel filtration analyses of P. furiosus Rad50 Hk14 and Hk45 peptides were conducted in 20 mM Tris pH 7.4 with 150 mM NaF using the Dionex Ultimate 3000 HPLC chromatography system equipped with a Shodex KW402.5‐4F column. 5 μL of 1 mM and 0.5 mM Hk14 and Hk45, respectively, dissolved in the running phase, were injected by the autosampler onto the column running at a 0.25 mL min−1 flow rate with detector wavelengths set to 220 and 280 nm. Samples were prepared and resolved in the order of 0 to 0.45 and 0.9 molar equivalents of HgII, with a 10‐min incubation period prior the injection and 2 CV column washes between the runs.
Fluorescence anisotropy decay: Anisotropy decay studies were performed with a DeltaFlex TCSPC Fluorimeter (Horiba) equipped with a Peltier‐thermostatted cell holder. All measurements were carried out at 294 K in 50 mM HEPES, pH 7.4, 150 mM NaCl, 3.5 μM DTT buffer. 400 μL of 350 nM FAM‐labeled Hk14 and Hk45 was placed in a 1 mL all‐transparent quartz cuvette and excited with a linearly polarized laser from DeltaDiode DD‐485L (wavelength of 485±10 nm, operating at 8.4 MHz) through a 4 nm slit. Emission data were detected at 521 nm wavelength with a sequentially changing polarizer from 0° to 90° until accumulation of a 10,000 peak difference at a 100 ns timescale was reached. Time of a single measurement was set to 1 s. Decay data were subsequently fitted with DAS6 software using two‐exponential fitting, as VV+VH sum and VV−VH difference, and anisotropy. Given the very small targets (Hk14–Hk45 peptides), only difference spectra from reconvolution anisotropy analyses were taken into account. [33]
Isothermal titration calorimetry (ITC): The binding of HgII to Hk14 was monitored using a Nano‐ITC calorimeter (TA Instruments, USA) at 25 °C with an active cell volume of 1 mL. All experiments were performed in 50 mM HEPES buffer, pH 7.4, containing 150 mM NaNO3. The use of NaNO3 in case of titration with HgII was deliberate, and was dictated by the fact of the interaction of HgII and Cl−. The Hk14 concentration was 0.2 mM, whereas that of the titrant (ZnSO4, CdSO4 or Hg(NO3)2) was 1.3 mM. All titrant solutions were prepared freshly just before measurement, and concentration were confirmed with PAR assays. [87] After initial temperature equilibration, a total volume of 98.01 μL of the titrant was injected continuously over 40 min with stirring at 200 rpm. We decided to use continuous ITC (cITC) due to the observable decrease of the Hg(NO3)2 concentration in the solution. To determine the heats of titrant dilution, control experiments were performed with identical parameters but in the absence of peptide in the cell. The titration data were analyzed in NanoAnalyze (version 3.3.0). First, data were preprocessed in NanoAnalyze by determining the baseline and then subtracting the heats of dilution. From such pre‐processed data ▵H ITC was calculated by averaging the plateau corresponding to the formation of the 1 : 2 complex. Data were not fitted to any kind of model, as Hk14 complexes with metal are characterized by a binding constant outside the measurable range.
Conflict of interest
The authors declare no conflict of interest.
1.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Acknowledgements
This research and the authors were supported by the Polish National Science Centre (NCN) under Opus grant no. 2016/21/B/NZ1/02847. The authors thank Prof. Peter Waaben Thulstrup and Miłosz Nowak for their assistance in PAC and UV‐Vis/CD measurements, respectively.
M. Łuczkowski, M. Padjasek, J. Ba Tran, L. Hemmingsen, O. Kerber, J. Habjanič, E. Freisinger, A. Krężel, Chem. Eur. J. 2022, 28, e202202738.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Bebout D. C. in Encyclopedia of Inorganic and Bioinorganic Chemistry, “Mercury: Inorganic & Coordination Chemistry”, Wiley, 2011. [Google Scholar]
- 2. Enescu M., Manceau A., Theor. Chem. Acc. 2014, 133: 1457. [Google Scholar]
- 3. Manceau A., Nagy K. L., Dalton Trans. 2008, 1421–1425. [DOI] [PubMed] [Google Scholar]
- 4. Orpen A. G., Brammer L., Allen F. H., Kennard O., Watson D. G., Taylor R., J. Chem. Soc. Dalton Trans. 1989, S1–S83. [Google Scholar]
- 5. Cottrell T. L., in The Strengths of Chemical Bonds, Butterworths, London, 1954, p. 310. [Google Scholar]
- 6. Govindaswamy N., Moy J., Millar M., Koch S. A., Inorg. Chem. 1992, 31, 5343–5344. [Google Scholar]
- 7. Chakraborty S., Touw D. S., Peacock A. F., Stuckey J., Pecoraro V. L., J. Am. Chem. Soc. 2010, 132, 13240–13250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Crichton R. R., Biological Inorganic Chemistry: A New Introduction to Molecular Structure and Function, 2 nd ed., Elsevier, Oxford, 2012, p. 460. [Google Scholar]
- 9. Bernhoft R. A., J. Environ. Public Health 2012, 2012, 460508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Barkay T., Miller S. M., Summers A. O., FEMS Microbiol. Rev. 2003, 27, 355–384. [DOI] [PubMed] [Google Scholar]
- 11. Bernhard W., Good M., Vašák M., Kägi J. H., Inorg. Chim. Acta 1983, 79, 154–155. [Google Scholar]
- 12. Krężel A., Maret W., Chem. Rev. 2021, 121, 14594–14648. [DOI] [PubMed] [Google Scholar]
- 13. Jalilehvand F., Parmar K., Zielke S., Metallomics 2013, 5, 1368–1376. [DOI] [PubMed] [Google Scholar]
- 14. Jalilehvand F., Leung B. O., Izadifard M., Damian E., Inorg. Chem. 2006, 45, 66–73. [DOI] [PubMed] [Google Scholar]
- 15. Faller P., Ctortecka B., Tröger W., Butz T., Vasák M., J. Biol. Inorg. Chem. 2000, 5, 393–401. [DOI] [PubMed] [Google Scholar]
- 16. Bourdineaud J. P., Gonzalez-Rey M., Rovezzi M., Glatzel P., Nagy K. L., Manceau A., Environ. Sci. Technol. 2019, 53, 4880–4891. [DOI] [PubMed] [Google Scholar]
- 17. Manceau A., Bustamante P., Haouz A., Bourdineaud J. P., Gonzalez-Rey M., Lemouchi C., Gautier-Luneau I., Geertsen V., Barruet E., Rovezzi M., Glatzel P., Pin S., Chem. Eur. J. 2019, 25, 997–1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Palacios Ò., Capdevila M. in Encyclopedia of Metalloproteins (Eds.: Kretsinger R. H., Uversky V. N., Permyakov E. A.), Springer, New York, 2013, pp. 1386–1390. [Google Scholar]
- 19. Church W. B., Guss J. M., Potter J. J., Freeman H. C., J. Biol. Chem. 1986, 261, 234–237. [DOI] [PubMed] [Google Scholar]
- 20. Utschig L. M., Bryson J. W., O′Halloran T. V., Science 1995, 268, 380–385. [DOI] [PubMed] [Google Scholar]
- 21. Stratton A., Ericksen M., Harris T. V., Symmonds N., Silverstein T. P., Protein Sci. 2017, 26, 292–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Domínguez-Calva J. A., Pérez-Vázquez M. L., Serebryany E., King J. A., Quintanar L., J. Biol. Inorg. Chem. 2018, 23, 1105–1118. [DOI] [PubMed] [Google Scholar]
- 23. Łuczkowski M., De Ricco R., Stachura M., Potocki S., Hemmingsen L., Valensin D., Metallomics 2015, 7, 478–490. [DOI] [PubMed] [Google Scholar]
- 24. Tran J. B., Krężel A., J. Proteome Res. 2021, 20,1889–1901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Wallin C., Jarvet J., Biverstål H., Wärmländer S., Danielsson J., Gräslund A., Abelein A., J. Biol. Chem. 2020, 295, 7224–7234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Pecoraro V. L., Peacock A. F. A., Iranzo O., Łuczkowski M., ACS Symp. Ser. 2009, 1012, 183–197. [Google Scholar]
- 27. Wernimont A. K., Huffman D. L., Lamb A. L., O′Halloran T. V., Rosenzweig A. C., Nat. Struct. Biol. 2000, 7, 766–771. [DOI] [PubMed] [Google Scholar]
- 28. Łuczkowski M., Zeider B. A., Hinz A. V., Stachura M., Chakraborty S., Hemmingsen L., Huffman D. L., Pecoraro V. L., Chem. Eur. J. 2013, 19, 9042–9049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Kochańczyk T., Drozd A., Krężel A., Metallomics 2015, 7, 244–257. [DOI] [PubMed] [Google Scholar]
- 30. Kocyła A., Tran J. B., Krężel A., Trends Biochem. Sci. 2021, 46, 64–79. [DOI] [PubMed] [Google Scholar]
- 31. Sharples G. J., Leach D. R., Mol. Microbiol. 1995, 17, 1215–1217. [DOI] [PubMed] [Google Scholar]
- 32. Hopfner K. P., Craig L., Moncalian G., Zinkel R. A., Usui T., Owen B. A., Karcher A., Henderson B., Bodmer J. L., McMurray C. T., Carney J. P., Petrini J. H., Tainer J. A., Nature 2002, 418, 562–566. [DOI] [PubMed] [Google Scholar]
- 33. Padjasek M., Maciejczyk M., Nowakowski M., Kerber O., Pyrka M., Koźmiński W., Krężel A., Chem. Eur. J. 2020, 26, 3297–3313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Syed A., Tainer J. A., Annu. Rev. Biochem. 2018, 87, 263–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Casari E., Rinaldi C., Marsella A., Gnugnoli M., Colombo C. V., Bonetti D., Longhese M. P., Front. Mol. Biosci. 2019, 6, 43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Stracker T. H., Petrini J. H., Nat. Rev. Mol. Cell Biol. 2011, 12, 90–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lafrance-Vanasse J., Williams G. J., Tainer J. A., Prog. Biophys. Mol. Biol. 2015, 117, 182–193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Kochańczyk T., Jakimowicz P., Krężel A., Chem. Commun. (Camb.) 2013, 49, 1312–1314. [DOI] [PubMed] [Google Scholar]
- 39. Kochańczyk T., Nowakowski M., Wojewska D., Kocyła A., Ejchart A., Koźmiński W., Krężel A., Sci. Rep. 2016, 6, 36346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Park Y. B., Hohl M., Padjasek M., Jeong E., Jin K. S., Krężel A., Petrini J. H., Cho Y., Nat. Struct. Mol. Biol. 2017, 24, 248–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Padjasek M., Kocyła A., Kluska K., Kerber O., Tran J. B., Krężel A., J. Inorg. Biochem. 2020, 204, 110955. [DOI] [PubMed] [Google Scholar]
- 42. Ajsuvakova O. P., Tinkov A. A., Aschner M., Rocha J. B. T., Michalke B., Skalnaya M. G., Skalny A. V., Butnariu M., Dadar M., Sarac I., Aaseth J., Bjørklund G., Coord. Chem. Rev. 2020, 417, 213343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Pufahl R. A., Singer C. P., Peariso K. L., Lin S. J., Schmidt P. J., Fahrni C. J., Culotta V. C., Penner Hahn J. E., O'Halloran T. V., Science 1997, 278, 853–856. [DOI] [PubMed] [Google Scholar]
- 44. Veglia G., Porcelli F., DeSilva T., Prantner A., Opella S. J., J. Am. Chem. Soc. 2000, 122, 2389–2390. [Google Scholar]
- 45. Butz T., Tröger W., Pöhlmann T., Nuyken O., Z. Naturforsch. A 1992, 47, 85–88. [Google Scholar]
- 46. Iranzo O., Thulstrup P. W., Ryu S. B., Hemmingsen L., Pecoraro V. L., Chem. Eur. J. 2007, 13, 9178–9190. [DOI] [PubMed] [Google Scholar]
- 47. Jancsó A., Correia J. G., Balogh R. K., Schell J., Jensen M. L., Szunyogh D., Thulstrup P. W., Hemmingsen L., Nucl. Instrum. Methods Phys. Res. Sect. A 2021, 1002, 165154. [Google Scholar]
- 48. Hopfner K. P., Karcher A., Craig L., Woo T. T., Carney J. P., Tainer J. A., Cell 2001, 105, 473–485. [DOI] [PubMed] [Google Scholar]
- 49. Winther J. R., Thorpe C., Biochim. Biophys. Acta. 2014, 1840, 838–884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Lu W., Stillman M., J. Am. Chem. Soc. 1993, 115, 3291–3299. [Google Scholar]
- 51. Łuczkowski M., Stachura M., Schirf V., Demeler B., Hemmingsen L., Pecoraro V. L., Inorg. Chem. 2008, 47, 10875–10888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Graddis T. J., Myszka D. G., Chaiken I. M., Biochemistry 1993, 32, 12664–12671. [DOI] [PubMed] [Google Scholar]
- 53. Lakowicz J. R., in Principles of Fluorescence Spectroscopy, Springer, Berlin, 2010, p. 954. [Google Scholar]
- 54. Casas J. S., Jones M. M., J. Inorg. Nucl. Chem. 1980, 42, 99–102. [Google Scholar]
- 55. Kluska K., Adamczyk J., Krężel A., Coord. Chem. Rev. 2018, 367, 18–64. [Google Scholar]
- 56. Miłoch A., Krężel A., Metallomics 2014, 6, 2015–2024. [DOI] [PubMed] [Google Scholar]
- 57. Alkhamis O., Yang W., Farhana R., Yu H., Xiao Y., Nucleic Acids Res. 2020, 48, e120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Dumas P., Eur. Biophys. J. 2022, 51, 77–84. [DOI] [PubMed] [Google Scholar]
- 59. Markova N., Hallén D., Anal. Biochem. 2004, 331, 77–88. [DOI] [PubMed] [Google Scholar]
- 60. Krężel A., Wójcik J., Maciejczyk M., Bal W., Chem. Commun. (Camb.) 2003, 704–705. [DOI] [PubMed] [Google Scholar]
- 61. Krężel A., Maret W., Arch. Biochem. Biophys. 2016, 611, 3–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Connelly J. C., Leach D. R. F., Trends Biochem. Sci. 2002, 27, 410–418. [DOI] [PubMed] [Google Scholar]
- 63. Käshammer L., Saathoff J. H., Lammens K., Gut F., Bartho J., Alt A., Kessler B., Hopfner K. P., Mol. Cell 2019, 76, 382–394.e6. [DOI] [PubMed] [Google Scholar]
- 64. Hopfner K. P., Karcher A., Shin D. S., Craig L., Arthur L. M., Carney J. P., Tainer J. A., Cell 2000, 101, 789–800. [DOI] [PubMed] [Google Scholar]
- 65. Hohl M., Kochańczyk T., Tous C., Aguilera A., Krężel A., Petrini J. H., Mol. Cell 2015, 57, 479–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Hohl M., Kwon Y., Galván S. M., Xue X., Tous C., Aguilera A., Sung P., Petrini J. H. J., Nat. Struct. Mol. Biol. 2011, 18, 1124–1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Deshpande R. A., Williams G. J., Limbo O., Williams R. S., Kuhnlein J., Lee J. H., Classen S., Guenther G., Russell P., Tainer J. A., Paull T. T., EMBO J. 2014, 33, 482–500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Lee J. H., Mand M. R., Deshpande R. A., Kinoshita E., Yang S. H., Wyman C., Paull T. T., J. Biol. Chem. 2013, 288, 12840–12851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Bryan S. E., Lambert C., Hardy K. J., Simons S., Science 1974, 186, 832–833. [DOI] [PubMed] [Google Scholar]
- 70. Bryan S. E., Guy A. L., Hardy K. J., Biochemistry 1974, 13, 313–319. [DOI] [PubMed] [Google Scholar]
- 71. Różalski M., Wierzbicki R., Environ. Res. 1979, 20, 465–9. [DOI] [PubMed] [Google Scholar]
- 72. Różalski M., Kuziemska E., Wierzbicki R., Biochem. Pharmacol. 1981, 30, 2177–2178. [DOI] [PubMed] [Google Scholar]
- 73. Różalski M., Wierzbicki R., Biochem. Pharmacol. 1983, 32, 2124–2126. [DOI] [PubMed] [Google Scholar]
- 74. Christensen M., Mogensen S. C., Rungby J., Arch. Toxicol. 1988, 62, 440–446. [DOI] [PubMed] [Google Scholar]
- 75. Bucio L., García C., Souza V., Hernández E., González C., Betancourt M., Gutiérrez-Ruiz M. C., Mutat. Res. 1999, 423, 65–72. [DOI] [PubMed] [Google Scholar]
- 76. Rodgers J. S., Hocker J. R., Hanas R. J., Nwosu E. C., Hanas J. S., Biochem. Pharmacol. 2001, 61, 1543–1550. [DOI] [PubMed] [Google Scholar]
- 77. Pamphlett R., Kum Jew S., Front. Med. 2019, 6, 168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Pamphlett R., Satgunaseelan L., Kum Jew S., Doble P. A., Bishop D. P., PLoS One 2020, 15:e0228226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Pomorski A., Kochańczyk T., Miłoch A., Krężel A., Anal. Chem. 2013, 85, 11479–11486. [DOI] [PubMed] [Google Scholar]
- 80. Eyer P., Worek F., Kiderlen D., Sinko G., Stuglin A., Simeon-Rudolf V., Reiner E., Anal. Biochem. 2003, 312, 224–227. [DOI] [PubMed] [Google Scholar]
- 81. Drozd A., Wojewska D., Peris-Diaz M. D., Jakimowicz P., Krężel A., Metallomics 2018, 10, 595–613. [DOI] [PubMed] [Google Scholar]
- 82. Vasák M., Kägi J. H., Hill H. A., Biochemistry 1981, 20, 2852–2856. [DOI] [PubMed] [Google Scholar]
- 83. Balogh R. K., Gyurcsik B., Hunyadi-Gulyás É., Schell J., Thulstrup P. W., Hemmingsen L., Jancsó A., Chem. Eur. J. 2019, 25, 15030–15035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Sénèque O., Rousselot-Pailley P., Pujol A., Boturyn D., Crouzy S., Proux O., Manceau A., Lebrun C., Delangle P., Inorg. Chem. 2018, 57, 2705–2713. [DOI] [PubMed] [Google Scholar]
- 85. Klose G., Volke F., Peinel G., Knobloch G., Magn. Reson. Chem. 1993, 31, 548–551. [Google Scholar]
- 86. Hemmingsen L., Sas K. N., Danielsen E., Chem. Rev. 2004, 104, 4027–4062. [DOI] [PubMed] [Google Scholar]
- 87. Kocyła A., Pomorski A., Krężel A., J. Inorg. Biochem. 2015, 152, 82–92. [DOI] [PubMed] [Google Scholar]
- 88. Anderegg G., Helv. Chim. Acta 1957, 40, 1022–1026. [Google Scholar]
- 89. Basinger M. A., Casas J. S., Jones M. M., Weaver A. D., Weinstein N. H., J. Inorg. Nucl. Chem. 1981, 43, 1419–1425. [Google Scholar]
- 90. Starý J., Kratzer K., J. Radioanal. Nucl. Chem. 1988, 126, 69–75. [Google Scholar]
- 91. Cardiano P., Falcone G., Foti C., Sammartano S., J. Chem. Eng. Data 2011, 56, 4741–4750. [Google Scholar]
- 92. Fazary A. E., Awwad N. S., Ibrahium H. A., Shati A. A., Alfaifi M. Y., Ju Y. H., ACS Omega 2020, 5, 19598–19605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Oram P. D., Fang X., Fernando Q., Letkeman P., Letkeman D., Chem. Res. Toxicol. 1996, 9, 709–712. [DOI] [PubMed] [Google Scholar]
- 94. Stricks W., Kolthoff I. M., J. Am. Chem. Soc. 1953, 75, 5673–5681. [Google Scholar]
- 95. Martell A. E., Smith R. M., in Critical Stability Constants, Vol. 5, Springer, Boston, 1982, p. 604. [Google Scholar]
- 96. Kõszegi-Szalai H., Paál T. L., Talanta 1999, 48, 393–402. [DOI] [PubMed] [Google Scholar]
- 97. Lenz G. R., Martell A. E., Biochemistry 1964, 3, 745–750. [DOI] [PubMed] [Google Scholar]
- 98. Kuchinskas E. J., Rosen Y., Arch. Biochem. Biophys. 1962, 97, 370–372. [DOI] [PubMed] [Google Scholar]
- 99. Van der Linden W. E., Beers C., Talanta 1975, 22, 89–92. [DOI] [PubMed] [Google Scholar]
- 100. Parkhill J., Ansari A. Z., Wright J. G., Brown N. L., O′Halloran T. V., EMBO J. 1993, 12, 413–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.


